Viewing Study NCT00522392

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2026-01-25 @ 6:38 AM
Study NCT ID: NCT00522392
Status: TERMINATED
Last Update Posted: 2015-06-26
First Post: 2007-08-28
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage I Multiple Myeloma View
None Stage II Multiple Myeloma View
None Stage III Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Consolidation therapy View
None First-line therapy View
None Proteasome inhibitor View
None Thalidomide analogue View
None Quality of life View